CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jan. 01, 2012	Jan. 02, 2011
Operating activities
Net income	$ 201,561	$ 242,439
Adjustments to net income to arrive at cash used for operating activities:
Depreciation	69,165	71,683
Amortization of intangible assets	8,357	8,388
Amortization of debt discount	10,651	12,795
Amortization of deferred financing costs	3,753	3,766
Deferred income taxes	(7,945)	14,703
(Gain) loss on disposal of property	(4,679)	2,560
Share-based plans expense	8,321	7,648
Excess tax benefits from share-based plans	(23)	(465)
Changes in assets and liabilities:
Net receivables	(112,251)	(221,033)
Net inventories	(91,197)	(33,496)
Accounts payable	(55,274)	(28,094)
Contract advances and allowances	(1,289)	15,698
Accrued compensation	(40,852)	(61,438)
Accrued income taxes	37,500	(41,384)
Pension and other postretirement benefits	25,780	66,638
Other assets and liabilities	73,162	66,297
Cash provided by operating activities	124,740	126,705
Investing activities
Capital expenditures	(97,916)	(72,986)
Acquisition of business (Note 4)		(172,251)
Proceeds from the disposition of property, plant, and equipment	7,329	333
Cash used for investing activities	(90,587)	(244,904)
Financing activities
Payments made on bank debt	(15,000)	(8,438)
Payments made to extinguish debt	(300,000)	(537,576)
Proceeds from issuance of long-term debt		750,000
Payments made for debt issue costs		(19,893)
Purchase of treasury shares	(49,991)
Dividends paid	(19,921)
Proceeds from employee stock compensation plans	3,943	7,645
Excess tax benefits from share-based plans	23	465
Cash (used for) provided by financing activities	(380,946)	192,203
(Decrease) Increase in cash and cash equivalents	(346,793)	74,004
Cash and cash equivalents - beginning of period	702,274	393,893
Cash and cash equivalents - end of period	355,481	467,897
Noncash investing activity:
Capital expenditures included in accounts payable	$ 2,102	$ 5,423